...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: got this & sent a response/follow up minutes before …

". As we know, the OTC is lightly regulated and considered by many to be a risky crapshoot. For that reason, trading is light (especially for a stock that is so cheap) and way below fair value"

I don't disagree with you but I do believe if any rumor(s) were true/legit deal was in the works & close someone would be buying now & at a higher price than what we've seen with decent volume.

Let me save you the trouble Don- Looks like we will have a deal by "June" now,for real lol 

Share
New Message
Please login to post a reply